PRN: Elsevier's BrainNavigator 3.2 Offers New Functionality to Speed Neurological Research
Elsevier's BrainNavigator 3.2 Offers New Functionality to Speed Neurological Research [15-November-2011] WALTHAM, Massachusetts, November 15, 2011 /PRNewswire/ -- - Digital research tool now includes cell counter and improved 3D models Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced new features for its online research tool BrainNavigator.
Elsevier's BrainNavigator 3.2 Offers New Functionality to Speed Neurological Research
WALTHAM, Massachusetts, November 15, 2011 /PRNewswire/ --
- Digital research tool now includes cell counter and improved 3D models
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced new features for its online research tool BrainNavigator. In the updated version, BrainNavigator 3.2, Elsevier has added critical new content and functionality to give researchers additional tools to accelerate their research.
This newest version, BrainNavigator 3.2, includes a "cell counter" that makes the tedious and time-consuming manual counting of cells obsolete. Neuroscientists use a method called "histology" to cut and stain brain slices to evaluate various compounds in particular brain regions. Â An accurate means of measuring these stains provides vital information about the way the brain works and what structures are involved in particular functions. Less expensive than high-end systems that are out-of-reach for most researchers, BrainNavigator's new counting tool allows researchers to mark cells systematically for easy analysis, minimizing the errors and miscalculations that often occur when using traditional manual methods.
BrainNavigator is an online, interactive, 3D software tool that extends and advances the application of brain atlases and maps images of brain anatomy, helping neuroscience researchers save time and improve the quality of their daily research. BrainNavigator helps locate the position of structures within the brain, making visualization and communication about scientific findings about the brain easier. The first version, introduced in 2009, received the prestigious PROSE Award in 2009. Updated versions with new features and functionalities have further enhanced the tool ever since.
In addition to the cell counter, BrainNavigator 3.2 includes improved 3D models based upon these atlases:
"We've launched yet another updated version of BrainNavigator with just one objective in mind: further improving the efficiency of the neuroscience researcher workflow," said Suzanne BeDell, Managing Director of Elsevier Science & Technology Books. "Their feedback will continue to be essential in our efforts to further improve our product in the future."
Offering both free and subscription-based content, BrainNavigator is used by the National Institutes of Health (NIH), Massachusetts Institute of Technology (MIT), Stanford University and other leading research institutions.Â Nothing in this press release constitutes or should be inferred to be an endorsement or recommendation of any product, service, or enterprise by the National Institutes of Health, any other agency of the United States Government, or any employee of the United States Government.
BrainNavigator is a collaboration between Elsevier and the Allen Institute for Brain Science, pairing Elsevier's vast neuroscience content with technology derived from Allen Institute's cutting-edge Brain ExplorerÂ® 3D software. Offering both free and subscription-based content, this dynamic new resource represents a promising step towards new discoveries in the advancement of brain research. All users will be able to browse images and structures. Paid subscribers will enjoy using high resolution images, adjustable virtual slicing and having the ability to annotate and save their work and share it with their colleagues globally, among other features. Details regarding BrainNavigator's functionality can be found at http://www.brainnav.com/info.
About the Allen Institute for Brain Science
The Allen Institute for Brain Science (http://www.alleninstitute.org) is an independent, 501(c)(3) nonprofit medical research organization dedicated to accelerating understanding of the human brain by fueling discovery for the broader scientific community. Through a product-focused approach, the Allen Institute generates innovative public resources used by researchers and organizations around the globe. Additionally, the Institute drives technological and analytical advances, thereby creating new knowledge and providing new ways to address questions about the brain in health and disease. Started with $100 million in seed money from philanthropist Paul G. Allen, the Institute is supported by a diversity of public and private funds. The Allen Institute's data and tools are publicly available online at http://www.brain-map.org.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliv! er better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Company Codes: LSE:REL, NYSE:RUK, NYSE:ENL